MicroRNAs and Long Non-coding RNAs Associated With Sirtuin Pathways in Myocardial Ischemia/Reperfusion Injury
Review article for Cardiovascular Drugs and Therapy (Springer Nature), March 2026
Sirtuins and regulatory miRNAs as epigenetic determinants of empagliflozin-mediated recovery after acute myocardial infarction
Journal paper for BMC Cardiovascular Diabetology (Springer Nature), December 2025, updated May 2026
Delphi-derived Framework for Healthspan-Oriented Care: The Cardiometabolic Health Perspective
Journal paper for Aging and Disease, June 2026
Targeting Inflammation in Obesity and the Cardiovascular-Kidney-Metabolic (CKM) Syndrome Spectrum: A Narrative Review
Review article for Karger Obesity Facts, June 2026
Clustering longitudinal multivariate trajectories using an ensemble of principal component trees
Journal paper for BMC Medical Research Methodology (Springer Nature), June 2026
Status of the PoCCardio point-of-care solution
Proteomic & genomic electrochemical sensors, microfluidic cartridges, sample preparation technologies and user instrumentation
Computational AI tool for predicting therapy response
The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.
The clinical trial has started
13 out of 29 study centres in Austria, Germany and Poland have begun recruiting participants for the trial of the PoCCardio point-of-care solution.
Novel clustering algorithm for enhancing the interpretability in patient stratification
The paper was prepared by the Medical University of Graz for the CIBB 2024 conference on Computational Intelligence methods for Bioinformatics and Biostatistics.
A new project partner
PoCCardio welcomes the Bioinformatics Department at CING - The Cyprus Institute of Neurology and Genetics
Project leaflet released
Have a look at our leaflet
PoCCardio on Austrian TV
Mobile device to replace laboratory tests
Identifying cardiovascular patients at high risk through finger-prick blood
PoCCardio is developing an innovative point-of-care tool using disease-specific markers from finger-prick blood for fast detection of heart patients at a very high risk of further cardiovascular events. Clinical validation involves more than 1800 patients from Austria,
